Muscle and bone loss is a common result of GLP-1 receptor agonist therapy
Potential risks include: Low blood sugar, especially if you also take other diabetes medications Gallbladder issues Mild to severe allergic reactions, including anaphylaxis in rare cases Possible muscle loss, if you lose weight too quickly (which is why balanced nutrition and movement matter) If youre pregnant or nursing, you should not take GLP-1s
The findings suggest semaglutide may be a preferred choice of GLP-1 RA for reducing cardiovascular risk in type 2 diabetes, offering clinicians valuable evidence to guide therapeutic decisions
Pharm 2022, Vol 14, Page 2432
Pomegranate (120mg): Bursting with essential nutrients and antioxidants, Pomegranate helps to rejuvenate the skin, diminishing the appearance of blemishes and enhancing its natural glow
This reveals that Ringer solution primes erythrocytes for eryptosis and/or that iRPMI protects erythrocytes from eryptosis